Next Generation News and Research

RSS

UT Southwestern Medical Center tops best hospital rankings for Dallas-Fort Worth

UT Southwestern Medical Center ranked as the best hospital in Dallas-Fort Worth in the newly expanded U.S. News & World Report's America's Best Hospitals rankings for 52 metropolitan areas.

30 Mar 2011

Transgenomic discovers novel BLOCker-Sequencing technology

Transgenomic, Inc. today announced that it has discovered a novel sequencing technology, which the company has termed BLOCker-Sequencing, which enhances the limit of detection of standard Sanger Sequencing, enriches for direct sequencing of mutated DNA over wild-type and can be run on standard Sanger Sequencing equipment.

30 Mar 2011

Onyx plans to expand carfilzomib Phase 3 European trial in patients with myeloma

Onyx Pharmaceuticals, Inc. today announced its plans to expand the Phase 3 European clinical trial FOCUS, which is evaluating the efficacy and tolerability of carfilzomib, a selective next-generation proteasome inhibitor.

29 Mar 2011

Positron to move PosiRx system to commercial deployment

Positron Corporation is pleased to announce that its PosiRx system has met critical test standards and guidelines necessary to move on to the commercial deployment stage of its development.

28 Mar 2011

Chembio develops DPP assay for rapid detection of HIV and HEP B/C

A kidney recipient in a New York City hospital recently contracted HIV from the transplanted organ, which came from a living donor, according to the New York State Department of Health. Although an initial screening had been performed on the donor, he or she apparently had unsafe sex after the test but before donating the kidney.

28 Mar 2011

Asbury Communities offers management and support services for older adults

In 2010, more than 4 million baby boomers turned 50, according to the U.S. Census Bureau. Boomers today represent 28 percent of the U.S. population, or 76.1 million people. With so many people aging, how is the senior living industry going to provide services to this group of older Americans?

28 Mar 2011

Jefferson Hospitals uses VMAT and Monte Carlo technology for accurate and fast radiation therapy

The Radiation Oncology Department at Thomas Jefferson University Hospitals is now treating cancer patients using a state-of-the-art VMAT technology based on the most accurate dose calculation algorithm that dramatically shortens treatment delivery time.

25 Mar 2011

VisualSonics introduces Vevo LAZR system to advance cancer research

VisualSonics Inc., a leader in real-time, in vivo, high-resolution micro-imaging systems and a wholly-owned subsidiary of SonoSite Inc., today announced the launch of the Vevo LAZR Photoacoustics Imaging system for the advancement of cancer research in the pre-clinical imaging market.

25 Mar 2011

FDA approves Medtronic's Consulta and Syncra pacemaker systems

Medtronic, Inc. today announced that the U.S. Food & Drug Administration has approved its Consulta and Syncra cardiac resynchronization therapy-pacemaker systems.

25 Mar 2011

MMRF hails new publication of multiple myeloma genome analysis in Nature journal

The Multiple Myeloma Research Foundation today hailed a new publication in Nature as a major step forward in the organization's efforts to advance a personalized medicine approach in multiple myeloma.

24 Mar 2011

Colorcon announces specific details on its patent positions for enteric coatings

Colorcon, Inc., a wholly owned subsidiary of BPSI Holdings Inc., today announced specific details on its world-wide patent positions for enteric coating compositions in response to misleading statements made in the international press, particularly in India.

24 Mar 2011

Loyola to open new nursing center for Collaborative Learning

Loyola University Chicago will break ground for the Marcella Niehoff School of Nursing Center for Collaborative Learning from 4-6 p.m., Saturday, April 9, at the health sciences campus at 2160 S. First Ave., Maywood, Ill.

24 Mar 2011

New insights into multiple myeloma research

Scientists have unveiled the most comprehensive picture to date of the full genetic blueprint of multiple myeloma, a form of blood cancer. A study of the genomes from 38 cancer samples has yielded new and unexpected insights into the events that lead to this form of cancer and could influence the direction of multiple myeloma research.

24 Mar 2011

New insights into cancer genome may lead to designer drugs for myeloma

Patients with myeloma could benefit from ‘designer’ drugs in the future after new genome-mapping technology has allowed scientists to identify a full genetic blueprint of the mutations which drive the bone marrow cancer.

23 Mar 2011

New study to provide better diagnoses for children with developmental disorders

A new UK study will provide better diagnoses for children with developmental disorders caused by changes in their genetic makeup. Scientists and clinicians will build a new national resource of genetic information and symptoms, based on data from 12,000 children who have a serious delay in their physical or mental development or are born with multiple malformations.

23 Mar 2011

More sensitive test to detect protein troponin associated with increased diagnosis of heart attacks

In patients with a suspected acute coronary syndrome (ACS; such as heart attack or unstable angina), use of a more sensitive test to detect the protein troponin in blood was associated with increased diagnosis of a heart attack and improved identification of patients at high risk of another heart attack and death in the following year, according to a study in the March 23/30 issue of JAMA.

23 Mar 2011

$FDA clears LensAR Laser System for use in refractive cataract surgery$

FDA clears LensAR Laser System for use in refractive cataract surgery

LensAR, Inc., the leading developer of next-generation laser technology for refractive cataract surgery, announced today that the company has received 510(k) clearance from the FDA for use of the LensAR™ Laser System for anterior capsulotomy and lens fragmentation during cataract surgery.

23 Mar 2011

CMU's CNAST receives DSF Charitable Foundation grant to develop novel biomedical tools

The DSF Charitable Foundation has given a $3.9 million grant to Carnegie Mellon University's Center for Nucleic Acids Science and Technology to further the development of novel biomedical tools targeted at monitoring and manipulating gene expression.

22 Mar 2011

Intravenous Phenoxodiol-cisplatin combination well tolerated in platinum resistant ovarian cancer

Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from a Phase II clinical trial of intravenous Phenoxodiol in combination with cisplatin in women with platinum-resistant ovarian cancer.

21 Mar 2011

WaferGen, NuGEN collaborate to develop integrated workflows for gene expression profiling and target enrichment

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, and NuGEN Technologies, Inc., a leader in innovative genomic samples preparation, today announced they will co-develop and co-market simple, seamlessly integrated workflows for gene expression profiling and target enrichment to enable researchers to more easily achieve high-throughput, high-density real-time PCR with small, degraded, and hard-to-replace clinical specimens, such as formalin fixed paraffin embedded tissue (FFPE).

21 Mar 2011

Next Generation News and Research

UT Southwestern Medical Center tops best hospital rankings for Dallas-Fort Worth

Transgenomic discovers novel BLOCker-Sequencing technology

Onyx plans to expand carfilzomib Phase 3 European trial in patients with myeloma

Positron to move PosiRx system to commercial deployment

Chembio develops DPP assay for rapid detection of HIV and HEP B/C

Asbury Communities offers management and support services for older adults

Jefferson Hospitals uses VMAT and Monte Carlo technology for accurate and fast radiation therapy

VisualSonics introduces Vevo LAZR system to advance cancer research

FDA approves Medtronic's Consulta and Syncra pacemaker systems

MMRF hails new publication of multiple myeloma genome analysis in Nature journal

Colorcon announces specific details on its patent positions for enteric coatings

Loyola to open new nursing center for Collaborative Learning

New insights into multiple myeloma research

New insights into cancer genome may lead to designer drugs for myeloma

New study to provide better diagnoses for children with developmental disorders

More sensitive test to detect protein troponin associated with increased diagnosis of heart attacks

FDA clears LensAR Laser System for use in refractive cataract surgery

CMU's CNAST receives DSF Charitable Foundation grant to develop novel biomedical tools

Intravenous Phenoxodiol-cisplatin combination well tolerated in platinum resistant ovarian cancer

WaferGen, NuGEN collaborate to develop integrated workflows for gene expression profiling and target enrichment

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News